Al founded Chestnut Partners in 1995. While at Chestnut, he has advised on over $11 billion in completed merger transactions and raised over $850 million in private and public debt and equity financings, including four IPOs. Prior to founding Chestnut Partners, Mr. Holman spent 14 years Kidder, Peabody & Co. Incorporated. Before moving to Boston in 1993, he was based in New York and was the Head of the Life Science and Technology Finance Groups, Co-Head of the Domestic Generalist Coverage Group, Head of the Emerging Growth Group with responsibilities for private growth companies and Co-Head of the Japan Banking Group. At Kidder, Mr. Holman publicly and privately raised over $2 billion of capital including 10 initial public offerings (including lead IPO banker for Genzyme and Vertex Pharmaceuticals) and completed numerous acquisitions, divestitures, joint ventures and tender defense assignments. He previously chaired Kidder’s Mergers and Acquisition Department’s Fairness Opinion Committee and co-chaired the Investment Banking Department’s Year-end Management Committee. Mr. Holman is a graduate of Harvard University’s Graduate School of Business Administration and the University of Michigan.
Mr. Holman is a Trustee of Mass General Brigham (formerly Partners HealthCare) where he chairs the Finance Committee and is a member of the Investment and Audit and Compliance Committees. Mr. Holman is also a Trustee of the Boston Symphony Orchestra, Inc. (member of Executive, Philanthropy (co-head), and Finance Committees). He is a Trustee Emeritus of the Boston Ballet and past co-chair of its Governance Committee.
Registrations: FINRA Series 24, 79, 7, and 63.
